Trilostane for Androgen-Independent Prostate Cancer

Clinical trial NCT00181597 · COMPLETED

Trial details

NCT number: NCT00181597
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Adenocarcinoma

Start date: 2004-03-01
Primary completion: 2006-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.